Cigna Investments’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-699
Closed -$216K – 476
2025
Q3
$216K Hold
699
– – 0.03% 439
2025
Q2
$220K Buy
+699
New +$202K 0.04% 423
2023
Q3
– Sell
-833
Closed -$241K – 455
2023
Q2
$241K Buy
833
+10
+1% +$3.04K 0.04% 397
2023
Q1
$263K Buy
823
+76
+10% +$22.5K 0.05% 369
2022
Q4
$220K Buy
+747
New +$206K 0.05% 408
2020
Q3
– Sell
-1,108
Closed -$215K – 735
2020
Q2
$215K Buy
+1,108
New +$212K 0.02% 656

Other funds holding PODD

Cigna Investments's PODD Position: Q4 2025 in Review

Cigna Investments sold out of Insulet (PODD) in Q4 2025, closing a stake of 699 shares — an estimated $216K sold.

Cigna Investments first reported a position in PODD in Q2 2020 and held it in 6 quarters. The position peaked at $263K in Q1 2023. 834 funds tracked by Wall St. Rank hold PODD as of Q4 2025.

  • Cigna Investments reported no remaining Insulet position as of Q4 2025 after selling out during the quarter.
  • Cigna Investments sold 699 Insulet shares in Q4 2025, an estimated $216K.
  • Cigna Investments first reported a position in Insulet in Q2 2020 and held it in 6 quarters.
  • Cigna Investments's Insulet position peaked at $263K in Q1 2023.
  • 834 funds tracked by Wall St. Rank held Insulet as of Q4 2025.

Based on Cigna Investments's 13F filing for Q4 2025, filed 20 Jan 2026.